thymidine has been researched along with Acquired Immune Deficiency Syndrome in 168 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the development of anemia as part of a trial of zidovudine therapy in patients with the acquired immunodeficiency syndrome (AIDS) with Kaposi sarcoma." | 9.06 | Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. ( Carleton, S; Fauci, AS; Gralnick, HR; Kirk, LE; Kovacs, JA; Lane, HC; Masur, H; Parker, RI; Walker, RE, 1988) |
| "We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex." | 9.06 | The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Hirsch, MS; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Volberding, PA, 1987) |
| "We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by Pneumocystis carinii pneumonia alone, or with advanced AIDS-related complex." | 9.06 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Schooley, RT; Volberding, PA, 1987) |
| "Eight children with acquired immunodeficiency syndrome (AIDS), aged four months to 12 years, were treated with zidovudine (azidothymidine) 100 mg/m2 intravenously every six hours for 14 days, followed by oral zidovudine at the same dose for a total of six months." | 7.67 | Zidovudine therapy in children with acquired immunodeficiency syndrome. ( Blanche, S; Burgard, M; Caniglia, M; Duhamel, G; Fischer, A; Griscelli, C; Rouzioux, C; Tardieu, M, 1988) |
| "Zidovudine was present in the semen and serum of six patients with acquired immunodeficiency syndrome or the related complex who were receiving 200 mg of the drug orally every four to six hours." | 7.67 | Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. ( Balfour, HH; Chinnock, BJ; de Miranda, P; Fletcher, CV; Henry, K; Quinn, RP, 1988) |
| "Six HIV-antigenaemic patients with AIDS or AIDS-related complex were studied to assess the effect of treatment with low-dose zidovudine (250 mg) in 6-hourly doses on HIV antigen (HIV-Ag) levels in cerebrospinal fluid (CSF)." | 7.67 | Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine. ( Cload, P; Danner, SA; de Gans, J; de Wolf, F; Derix, MM; Eeftinck Schattenkerk, JK; Goudsmit, J; Lange, JM; Ongerboer de Visser, BW, 1988) |
| "A patient with AIDS-related thrombocytopenia (ART) was treated with the new anti-retroviral agent azidothymidine (AZT, Retrovir, zidovudine) by the intravenous and oral routes for a period of 20 weeks." | 7.67 | Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine). ( Chafey, S; Gottlieb, MS; Wolfe, PR, 1987) |
| "On the basis of observation that acyclovir potentiates the in-vitro antiviral activity of 3-azido-2',3'-dideoxythymidine (also known as azidothymidine or zidovudine) against human immunodeficiency virus (HIV), we administered a regimen of azidothymidine and acyclovir to eight patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex." | 7.67 | Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study. ( Allain, JP; Blum, MR; Lehrman, SN; Leuther, M; Maha, M; McAtee, N; Mitsuya, H; Surbone, A; Thomas, RV; Yarchoan, R, 1988) |
| "Among 16 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex studied serially, 12 had or developed antigenemia ranging from 16 to 3006 pg/mL in plasma." | 6.66 | Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). ( Despotes, JC; Emeson, EE; Falk, LA; Jackson, GG; Knigge, M; Mack, D; Paul, DA; Rubenis, M, 1988) |
| "Four patients with the acquired immunodeficiency syndrome, and a history of Pneumocystis carinii pneumonia developed severe pancytopenia (hemoglobin, less than 85 g/L; granulocytes, less than or equal to 0." | 5.27 | Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). ( Brynes, RK; Causey, D; Gill, PS; Levine, AM; Loureiro, C; Rarick, M, 1987) |
| "In a 6-week clinical trial 4 dose regimens of 3'-azido-3'-deoxythymidine (AZT), a thymidine analogue with potent anti-viral activity against HTLV-III in vitro, were examined in 19 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC)." | 5.06 | Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. ( Barry, DW; Blum, RM; Durack, DT; Gelmann, E; Klecker, RW; Lehrman, SN; Lyerly, HK; Markham, PD; Weinhold, KJ; Yarchoan, R, 1986) |
| "We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex." | 5.06 | The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Hirsch, MS; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Volberding, PA, 1987) |
| "We evaluated the development of anemia as part of a trial of zidovudine therapy in patients with the acquired immunodeficiency syndrome (AIDS) with Kaposi sarcoma." | 5.06 | Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. ( Carleton, S; Fauci, AS; Gralnick, HR; Kirk, LE; Kovacs, JA; Lane, HC; Masur, H; Parker, RI; Walker, RE, 1988) |
| "We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by Pneumocystis carinii pneumonia alone, or with advanced AIDS-related complex." | 5.06 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. ( Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Schooley, RT; Volberding, PA, 1987) |
| "3'-Azido-2',3'-dideoxythymidine (AZT) has been administered to 7 patients with human immunodeficiency virus-associated neurological disease: 3 with dementia, 2 with peripheral neuropathy, 1 with dementia and peripheral neuropathy, and 1 with T-10 paraplegia." | 5.06 | Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease. ( Berg, G; Dalakas, M; Fischl, M; Grafman, J; Klecker, RW; McAtee, N; Perno, CF; Thomas, RV; Wichman, A; Yarchoan, R, 1988) |
| "18 men with longstanding human immunodeficiency virus (HIV) antigenaemia but no symptoms received zidovudine in low-dose regimens (250 mg 6-hourly, 500 mg 6-hourly, or 500 mg 12-hourly) with or without acyclovir." | 5.06 | Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. ( Cload, P; Coutinho, RA; de Gans, J; de Wolf, F; Fiddian, AP; Goudsmit, J; Lange, JM; Schellekens, PT; van der Noordaa, J, 1988) |
| "Zidovudine (AZT, 3'-azido-3'-deoxythymidine) was shown in a controlled trial to decrease the incidence of mortality, reduce the frequency of opportunistic infections, and provide other clinical benefits to patients with acquired immune deficiency syndrome (AIDS) and advanced AIDS-related complex." | 5.06 | Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. ( Andrews, J; Richman, DD, 1988) |
| "We investigated the clinical pharmacokinetics of azidothymidine (N3TdR) as part of a phase I/II trial in the treatment of acquired immunodeficiency syndrome and related diseases." | 5.06 | Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. ( Broder, S; Collins, JM; Jenkins, JF; Klecker, RW; Myers, CE; Thomas, R; Yarchoan, R, 1987) |
| "Although control of AIDS will be a long and arduous journey, an important beginning has been made." | 3.76 | Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview. ( Hirsch, MS, 1988) |
| "On the basis of observation that acyclovir potentiates the in-vitro antiviral activity of 3-azido-2',3'-dideoxythymidine (also known as azidothymidine or zidovudine) against human immunodeficiency virus (HIV), we administered a regimen of azidothymidine and acyclovir to eight patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex." | 3.67 | Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study. ( Allain, JP; Blum, MR; Lehrman, SN; Leuther, M; Maha, M; McAtee, N; Mitsuya, H; Surbone, A; Thomas, RV; Yarchoan, R, 1988) |
| " Acyclovir has provided successful treatment in AIDS patients suffering from severe herpes simplex and herpes zoster virus infections." | 3.67 | Management of viral infections in AIDS patients. ( Drucker, JL; King, DH, 1987) |
| "A patient with AIDS-related thrombocytopenia (ART) was treated with the new anti-retroviral agent azidothymidine (AZT, Retrovir, zidovudine) by the intravenous and oral routes for a period of 20 weeks." | 3.67 | Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine). ( Chafey, S; Gottlieb, MS; Wolfe, PR, 1987) |
| "Due to similarities between human immunodeficiency virus and feline leukemia virus, the etiological agents of acquired immunodeficiency syndromes in humans and cats, the feline system was used as a model to conduct preliminary investigations as to the efficacy of the thymidine analogue 3'-azido-3'-deoxythymidine (AZT) as a therapeutic and preventive agent against retroviruses." | 3.67 | 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS. ( de Noronha, F; Johnston, K; Lehrman, SN; Roneker, C; Tavares, L, 1987) |
| "Six HIV-antigenaemic patients with AIDS or AIDS-related complex were studied to assess the effect of treatment with low-dose zidovudine (250 mg) in 6-hourly doses on HIV antigen (HIV-Ag) levels in cerebrospinal fluid (CSF)." | 3.67 | Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine. ( Cload, P; Danner, SA; de Gans, J; de Wolf, F; Derix, MM; Eeftinck Schattenkerk, JK; Goudsmit, J; Lange, JM; Ongerboer de Visser, BW, 1988) |
| "Zidovudine was present in the semen and serum of six patients with acquired immunodeficiency syndrome or the related complex who were receiving 200 mg of the drug orally every four to six hours." | 3.67 | Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. ( Balfour, HH; Chinnock, BJ; de Miranda, P; Fletcher, CV; Henry, K; Quinn, RP, 1988) |
| "Eight children with acquired immunodeficiency syndrome (AIDS), aged four months to 12 years, were treated with zidovudine (azidothymidine) 100 mg/m2 intravenously every six hours for 14 days, followed by oral zidovudine at the same dose for a total of six months." | 3.67 | Zidovudine therapy in children with acquired immunodeficiency syndrome. ( Blanche, S; Burgard, M; Caniglia, M; Duhamel, G; Fischer, A; Griscelli, C; Rouzioux, C; Tardieu, M, 1988) |
| "Five dose regimens of 2',3'-dideoxycytidine (ddC) were administered, intravenously for 2 weeks then orally for 4 or more weeks, to 20 patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC)." | 3.67 | Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). ( Allain, JP; Dubinsky, R; Fischl, MA; Klecker, RW; McAtee, N; McNeely, MC; Perno, CF; Thomas, RV; Wills, RJ; Yarchoan, R, 1988) |
| " Currently, acyclovir is the most effective agent for the treatment of herpes simplex and varicella-zoster virus infections." | 3.67 | Antiviral agents. ( Cockerill, FR; Hermans, PE, 1987) |
| "In a study of treatment by zidovudine in 106 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex, an acute meningo-encephalitic illness developed in 4 of 21 patients within 17 days after the dose of zidovudine had had to be reduced because of myelotoxicity." | 3.67 | Acute meningo-encephalitis on dose reduction of zidovudine. ( Forster, S; Helbert, M; Jeffries, D; Kocsis, A; Peddle, B; Pinching, AJ; Robinson, D, 1988) |
| "Among 16 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex studied serially, 12 had or developed antigenemia ranging from 16 to 3006 pg/mL in plasma." | 2.66 | Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). ( Despotes, JC; Emeson, EE; Falk, LA; Jackson, GG; Knigge, M; Mack, D; Paul, DA; Rubenis, M, 1988) |
| "1." | 2.39 | [In vitro synergic lymphocyte stimulation in HIV-1 infected patients using inosine derivatives and radio-detoxified endotoxin]. ( Bertók, L; Friedman, H; Hadden, JW; Nelson, R; Ongrádi, J; Specter, S, 1995) |
| "The end-stage of these infections, acquired immune deficiency syndrome (AIDS), was first recognised in 1981, and the causative agent isolated in 1983." | 2.37 | Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. ( Kaplan, JC; Sandström, EG, 1987) |
| "Patients with the acquired immunodeficiency syndrome (AIDS) die of overwhelming infections as a consequence of the destruction of the T4 subset of lymphocytes." | 2.37 | Developmental therapeutics and the acquired immunodeficiency syndrome. ( Broder, S; Chabner, BA; DeVita, VT; Fauci, AS; Kovacs, JA, 1987) |
| "Mental disturbances associated with acquired immunodeficiency syndrome (AIDS) are related not only to profound psychosocial stress, systemic diseases, and neoplasms or opportunistic infections within the central nervous system (CNS); they are also related to the direct neurotoxicity of the etiologic human immunodeficiency virus (HIV), producing an array of both insidious and acute affective, cognitive, and behavioral dysfunction that can mimic many neuropsychiatric disorders." | 2.37 | AIDS dementia: a review of the literature. ( Marotta, RF; Perry, S, 1987) |
| "Brain lesions in patients with AIDS were nonspecific regarding metabolic profile as determined with MR spectroscopic imaging." | 1.31 | Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. ( Barker, PB; Bizzi, A; Constantinides, CD; Dobgan, AS; McArthur, JC; Pomper, MG; Wong, DF; Yokoi, F, 2002) |
| "Although the total serum extracts from AIDS patients contained 1." | 1.29 | Perturbation of the immunosuppressive action of glucocorticoids in rat thymocytes by liposoluble extracts of serum from AIDS patients. ( Nunez, EA; Sumida, C; Thobie, N; Vallette, G, 1993) |
| "Thus AIDS-KS cells appear to be exquisitely sensitive to LED, which may provide a higher therapeutic to toxicity index in clinical use." | 1.29 | Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. ( Gill, P; Husain, SR; Masood, R; Rahman, A, 1993) |
| "We have shown that AIDS-KS spindle cells express IL-1 beta and that IL-1ra inhibits KS-spindle cell growth." | 1.29 | Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. ( Cai, J; Gill, P; Jung, B; Law, R; Lin, G; Louie, S; Lunardi-Iskandar, Y; Masood, R, 1995) |
| "[3H]Thymidine incorporation was decreased dose-dependently by dexamethasone in controls and patients; the effect was significantly blunted (P less than 0." | 1.28 | Cortisol resistance in acquired immunodeficiency syndrome. ( Baldi, G; Bertora, P; Bevilacqua, M; Chebat, E; Galli, M; Moroni, M; Norbiato, G; Oldenburg, N; Vago, T, 1992) |
| "The basic pharmacokinetic and bioavailability information on zidovudine was obtained during the initial phase I study." | 1.27 | Pharmacokinetics and bioavailability of zidovudine in humans. ( Blum, MR; de Miranda, P; Good, SS; Liao, SH, 1988) |
| "Patients with the acquired immunodeficiency syndrome (AIDS) more commonly have disseminated disease." | 1.27 | Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients. ( Cesario, T; Packer, SJ; Williams, JH, 1988) |
| "Four patients with the acquired immunodeficiency syndrome, and a history of Pneumocystis carinii pneumonia developed severe pancytopenia (hemoglobin, less than 85 g/L; granulocytes, less than or equal to 0." | 1.27 | Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). ( Brynes, RK; Causey, D; Gill, PS; Levine, AM; Loureiro, C; Rarick, M, 1987) |
| "Persons with the acquired immunodeficiency syndrome (AIDS) (n = 25), AIDS-related complex (n = 14), and HIV-seropositive men with only lymphadenopathy or no symptoms (n = 27)." | 1.27 | The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. ( Clements, ML; Cohn, S; Miotti, P; Nelson, KE; Polk, BF, 1988) |
| "We examined three patients with AIDS who had large, sharply demarcated areas of thinned retina consistent with inactive cytomegalovirus retinitis and who were not treated with ganciclovir." | 1.27 | Atypical retinitis in patients with the acquired immunodeficiency syndrome. ( Bozzette, S; Fay, MT; Freeman, WR; Hardy, D; Wiley, CA, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 150 (89.29) | 18.7374 |
| 1990's | 11 (6.55) | 18.2507 |
| 2000's | 7 (4.17) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oyugi, JO | 1 |
| Vouriot, FC | 1 |
| Alimonti, J | 1 |
| Wayne, S | 1 |
| Luo, M | 1 |
| Land, AM | 1 |
| Ao, Z | 1 |
| Yao, X | 1 |
| Sekaly, RP | 1 |
| Elliott, LJ | 1 |
| Simonsen, JN | 1 |
| Ball, TB | 1 |
| Jaoko, W | 1 |
| Kimani, J | 1 |
| Plummer, FA | 1 |
| Fowke, KR | 1 |
| Strazielle, N | 1 |
| Belin, MF | 1 |
| Ghersi-Egea, JF | 1 |
| de Mendoza, C | 1 |
| Paxinos, E | 1 |
| Barreiro, P | 1 |
| Camino, N | 1 |
| Núñez, M | 1 |
| Soriano, V | 1 |
| Miller, MD | 1 |
| Margot, N | 1 |
| Lu, B | 1 |
| Zhong, L | 1 |
| Chen, SS | 1 |
| Cheng, A | 1 |
| Wulfsohn, M | 1 |
| Flandre, P | 1 |
| Descamps, D | 1 |
| Joly, V | 1 |
| Meiffredy, V | 1 |
| Tamalet, C | 1 |
| Izopet, J | 1 |
| Brun-Vezinet, F | 1 |
| Gupta, S | 1 |
| Gillis, S | 1 |
| Thornton, M | 1 |
| Goldberg, M | 1 |
| Palladino, MA | 1 |
| Welte, K | 1 |
| Amaral, MC | 1 |
| Miles, S | 1 |
| Kumar, G | 1 |
| Nel, AE | 1 |
| Louie, S | 1 |
| Cai, J | 1 |
| Law, R | 1 |
| Lin, G | 1 |
| Lunardi-Iskandar, Y | 1 |
| Jung, B | 1 |
| Masood, R | 2 |
| Gill, P | 2 |
| Ongrádi, J | 1 |
| Hadden, JW | 1 |
| Bertók, L | 1 |
| Specter, S | 1 |
| Nelson, R | 1 |
| Friedman, H | 1 |
| Guo, WX | 1 |
| Antakly, T | 1 |
| Husain, SR | 1 |
| Rahman, A | 1 |
| Sumida, C | 1 |
| Vallette, G | 1 |
| Thobie, N | 1 |
| Nunez, EA | 1 |
| Velázquez, S | 1 |
| San-Félix, A | 1 |
| Pérez-Pérez, MJ | 1 |
| Balzarini, J | 2 |
| De Clercq, E | 3 |
| Camarasa, MJ | 1 |
| Ahmad, A | 1 |
| Ladha, A | 1 |
| Cohen, EA | 1 |
| Menezes, J | 1 |
| Pomper, MG | 1 |
| Constantinides, CD | 1 |
| Barker, PB | 1 |
| Bizzi, A | 1 |
| Dobgan, AS | 1 |
| Yokoi, F | 1 |
| McArthur, JC | 1 |
| Wong, DF | 1 |
| Campiani, G | 1 |
| Ramunno, A | 1 |
| Maga, G | 1 |
| Nacci, V | 1 |
| Fattorusso, C | 1 |
| Catalanotti, B | 1 |
| Morelli, E | 1 |
| Novellino, E | 1 |
| Inada, Y | 1 |
| Watanabe, K | 1 |
| Kamiyama, M | 1 |
| Kanemitsu, T | 1 |
| Clark, WS | 1 |
| Lange, M | 1 |
| Leung, LK | 1 |
| Kinkade, P | 1 |
| Wu, JM | 1 |
| Norbiato, G | 1 |
| Bevilacqua, M | 1 |
| Vago, T | 1 |
| Baldi, G | 1 |
| Chebat, E | 1 |
| Bertora, P | 1 |
| Moroni, M | 1 |
| Galli, M | 1 |
| Oldenburg, N | 1 |
| Mitsuya, H | 2 |
| Weinhold, KJ | 2 |
| Furman, PA | 1 |
| St Clair, MH | 1 |
| Lehrman, SN | 5 |
| Gallo, RC | 2 |
| Bolognesi, D | 1 |
| Barry, DW | 3 |
| Broder, S | 6 |
| Bean, B | 1 |
| Vogt, M | 1 |
| Schooley, RT | 4 |
| Hirsch, MS | 7 |
| DeVita, VT | 1 |
| Fauci, AS | 2 |
| Kovacs, JA | 2 |
| Chabner, BA | 1 |
| Kaplan, JC | 3 |
| Pedersen, C | 2 |
| Pomerantz, RJ | 1 |
| Lietman, PS | 1 |
| Clumeck, N | 1 |
| Hermans, P | 1 |
| Eck, HP | 1 |
| Gmünder, H | 1 |
| Hartmann, M | 1 |
| Petzoldt, D | 1 |
| Daniel, V | 1 |
| Dröge, W | 1 |
| Sandström, EG | 1 |
| Miller, JL | 1 |
| Brady, RO | 1 |
| O'Neill, RR | 1 |
| Yarchoan, R | 9 |
| Thomas, RV | 4 |
| Grafman, J | 2 |
| Wichman, A | 2 |
| Dalakas, M | 1 |
| McAtee, N | 3 |
| Berg, G | 2 |
| Fischl, M | 1 |
| Perno, CF | 2 |
| Klecker, RW | 4 |
| Büchi, ER | 1 |
| Bovey, EH | 1 |
| Michel, AE | 1 |
| Erard, PA | 1 |
| Chave, JP | 2 |
| Fay, MT | 1 |
| Freeman, WR | 1 |
| Wiley, CA | 1 |
| Hardy, D | 1 |
| Bozzette, S | 1 |
| Thurn, JR | 1 |
| Henry, K | 2 |
| Balfour, HH | 3 |
| D'Amico, DJ | 1 |
| Skolnik, PR | 1 |
| Kosloff, BR | 1 |
| Pinkston, P | 1 |
| Markham, PD | 1 |
| Lyerly, HK | 1 |
| Durack, DT | 1 |
| Gelmann, E | 1 |
| Blum, RM | 1 |
| Hagler, DN | 1 |
| Frame, PT | 1 |
| Brouwers, P | 2 |
| Fischl, MA | 4 |
| Spitzer, AR | 1 |
| Safai, B | 1 |
| Brunetti, A | 1 |
| Davtyan, DG | 1 |
| Vinters, HV | 1 |
| Ingeberg, S | 1 |
| Duvic, M | 1 |
| Rios, A | 1 |
| Brewton, GW | 1 |
| Bach, MC | 2 |
| Helbert, M | 3 |
| Stoneham, C | 1 |
| Mitchell, D | 1 |
| Pinching, AJ | 3 |
| Allain, JP | 3 |
| Wills, RJ | 1 |
| Dubinsky, R | 1 |
| McNeely, MC | 1 |
| Ruzicka, T | 1 |
| Fröschl, M | 1 |
| Hohenleutner, U | 1 |
| Holzmann, H | 1 |
| Braun-Falco, O | 1 |
| de Wolf, F | 2 |
| Lange, JM | 3 |
| Goudsmit, J | 3 |
| Cload, P | 2 |
| de Gans, J | 3 |
| Schellekens, PT | 1 |
| Coutinho, RA | 1 |
| Fiddian, AP | 1 |
| van der Noordaa, J | 1 |
| Reiss, P | 1 |
| Boucher, CA | 1 |
| Danner, SA | 2 |
| Meylan, PR | 1 |
| Francioli, P | 1 |
| Decrey, H | 1 |
| Glauser, MP | 1 |
| Fleury, HJ | 1 |
| Morere, G | 1 |
| Delord, B | 1 |
| Faivre, R | 1 |
| Robinson, D | 1 |
| Peddle, B | 2 |
| Forster, S | 1 |
| Kocsis, A | 1 |
| Jeffries, D | 1 |
| Ragni, MV | 1 |
| Tama, G | 1 |
| Lewis, JH | 1 |
| Ho, M | 1 |
| Steel, M | 1 |
| Youle, MM | 1 |
| Hawkins, DA | 1 |
| Collins, P | 1 |
| Shanson, DC | 1 |
| Evans, R | 1 |
| Oliver, N | 1 |
| Lawrence, A | 1 |
| Hargreaves, M | 1 |
| Fuller, G | 1 |
| Costello, C | 2 |
| Gazzard, B | 1 |
| Tiessens, G | 1 |
| Portegies, P | 1 |
| Fletcher, T | 1 |
| Harris, JR | 1 |
| Sandström, E | 1 |
| Weber, J | 1 |
| Surbone, A | 1 |
| Blum, MR | 2 |
| Maha, M | 1 |
| Leuther, M | 2 |
| Harle, JR | 1 |
| Disdier, P | 1 |
| Chouc, PY | 1 |
| Weiller, PJ | 1 |
| Nelson, KE | 1 |
| Clements, ML | 1 |
| Miotti, P | 1 |
| Cohn, S | 1 |
| Polk, BF | 1 |
| Riesenberg, DE | 1 |
| Marwick, C | 2 |
| Marx, JL | 1 |
| Barnes, DM | 5 |
| Tavares, L | 1 |
| Roneker, C | 1 |
| Johnston, K | 1 |
| de Noronha, F | 1 |
| Drucker, JL | 1 |
| King, DH | 1 |
| Offerhaus, L | 1 |
| LaFon, SW | 1 |
| Richman, DD | 3 |
| Andrews, J | 1 |
| Koshland, DE | 1 |
| Gottlieb, MS | 3 |
| Wolfe, PR | 1 |
| Chafey, S | 1 |
| Imai, H | 1 |
| Ikuta, K | 1 |
| Ueda, S | 1 |
| Suehiro, S | 1 |
| Yamamoto, N | 1 |
| Kato, S | 1 |
| Mir, N | 1 |
| Luckit, J | 1 |
| Jackson, GG | 1 |
| Paul, DA | 1 |
| Falk, LA | 1 |
| Rubenis, M | 1 |
| Despotes, JC | 1 |
| Mack, D | 1 |
| Knigge, M | 1 |
| Emeson, EE | 1 |
| Derix, MM | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| Ongerboer de Visser, BW | 1 |
| Roberts, DE | 1 |
| Berman, SM | 1 |
| Nakasato, S | 1 |
| Wyle, FA | 1 |
| Wishnow, RM | 1 |
| Segal, GP | 1 |
| Dalakas, MC | 1 |
| Spitzer, R | 1 |
| Elder, G | 1 |
| Sever, JL | 1 |
| Chinnock, BJ | 1 |
| Quinn, RP | 1 |
| Fletcher, CV | 1 |
| de Miranda, P | 2 |
| Goldman, B | 1 |
| Murray, RJ | 1 |
| Becker, P | 1 |
| Furth, P | 1 |
| Criner, GJ | 1 |
| Maxwell, S | 1 |
| Scheftner, WA | 1 |
| Kessler, HA | 1 |
| Busch, K | 1 |
| Permin, H | 1 |
| Dickmeiss, E | 1 |
| Colarian, J | 1 |
| Torrence, PF | 1 |
| Kinjo, J | 1 |
| Lesiak, K | 1 |
| Farrell, PL | 1 |
| Heinemann, MH | 1 |
| Roberts, CW | 1 |
| Polsky, B | 1 |
| Gold, JW | 1 |
| Mamelok, A | 1 |
| Nightingale, SL | 2 |
| Phelan, JA | 1 |
| Klein, RS | 1 |
| Liao, SH | 1 |
| Good, SS | 1 |
| Blanche, S | 1 |
| Caniglia, M | 1 |
| Fischer, A | 1 |
| Rouzioux, C | 1 |
| Burgard, M | 1 |
| Tardieu, M | 1 |
| Duhamel, G | 1 |
| Griscelli, C | 1 |
| Packer, SJ | 1 |
| Cesario, T | 1 |
| Williams, JH | 1 |
| Valencia, ME | 1 |
| Pintado, V | 1 |
| Lavilla, P | 1 |
| Gil Aguado, A | 1 |
| Pizzo, PA | 1 |
| Eddy, J | 1 |
| Falloon, J | 1 |
| Balis, FM | 1 |
| Murphy, RF | 1 |
| Moss, H | 1 |
| Wolters, P | 1 |
| Jarosinski, P | 1 |
| Rubin, M | 1 |
| Viens, P | 1 |
| Thyss, A | 1 |
| Garnier, G | 1 |
| Ayela, P | 1 |
| Coldiron, BM | 1 |
| Orcutt, VL | 1 |
| Barbaro, DJ | 1 |
| Blumenfeld, W | 1 |
| Basgoz, N | 1 |
| Owen, WF | 1 |
| Schmidt, DM | 1 |
| Azon-Masoliver, A | 1 |
| Mallolas, J | 1 |
| Gatell, J | 1 |
| Castel, T | 1 |
| Buchanan, RJ | 1 |
| Young, FE | 1 |
| Norris, JA | 1 |
| Levitt, JA | 1 |
| Barinaga, M | 1 |
| Ostrow, D | 1 |
| Grant, I | 1 |
| Atkinson, H | 1 |
| Erice, A | 1 |
| Rhame, FS | 1 |
| Dunn, DL | 1 |
| Chinnock, B | 1 |
| Rada, B | 1 |
| Grieco, MH | 2 |
| Volberding, PA | 3 |
| Laskin, OL | 2 |
| Leedom, JM | 2 |
| Groopman, JE | 3 |
| Mildvan, D | 2 |
| Brook, I | 1 |
| Perry, S | 1 |
| Marotta, RF | 1 |
| Feeney, GF | 1 |
| Frazer, I | 1 |
| Hymes, KB | 1 |
| Greene, JB | 2 |
| Karpatkin, S | 1 |
| Walker, RE | 1 |
| Parker, RI | 1 |
| Masur, H | 1 |
| Lane, HC | 1 |
| Carleton, S | 1 |
| Kirk, LE | 1 |
| Gralnick, HR | 1 |
| Bessen, LJ | 1 |
| Louie, E | 1 |
| Seitzman, P | 1 |
| Weinberg, H | 1 |
| Chaisson, RE | 1 |
| Kolata, G | 2 |
| DeHovitz, JA | 1 |
| Weissman, JB | 1 |
| Chandrasekar, PH | 1 |
| Macklin, R | 1 |
| Friedland, G | 1 |
| Cohen, SS | 1 |
| Forester, G | 1 |
| Gill, PS | 1 |
| Rarick, M | 1 |
| Brynes, RK | 1 |
| Causey, D | 1 |
| Loureiro, C | 1 |
| Levine, AM | 1 |
| Zuger, A | 1 |
| Phillips, AJ | 1 |
| Spence, AA | 1 |
| Jablon, L | 1 |
| Andes, WA | 1 |
| Panwalker, AP | 1 |
| Mirsky, H | 1 |
| Camsonne, R | 1 |
| Hurrault de Ligny, B | 1 |
| Letellier, P | 1 |
| Beleslin, DB | 1 |
| Furth, PA | 1 |
| Kazakis, AM | 1 |
| Flanigan, T | 1 |
| Shapiro, E | 1 |
| Graham, R | 1 |
| Hermans, PE | 1 |
| Cockerill, FR | 1 |
| Collins, JM | 1 |
| Thomas, R | 1 |
| Jenkins, JF | 1 |
| Myers, CE | 1 |
| Uretsky, SD | 1 |
| Dosne Pasqualini, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection[NCT00001443] | Phase 1 | 63 participants | Interventional | 1995-07-31 | Completed | ||
| A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine[NCT00001267] | Phase 3 | 42 participants | Interventional | 1990-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for thymidine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
[In vitro synergic lymphocyte stimulation in HIV-1 infected patients using inosine derivatives and radio-detoxified endotoxin].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Endotoxins; HIV Infections; HIV-1; | 1995 |
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzodiazepinones; Benzoxazines; Cyclo | 2002 |
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxyl | 1986 |
Developmental therapeutics and the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Deoxyribonucleosides; HIV; Humans; Interferons | 1987 |
Therapy of human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Humans; Immunotherapy; Interferons; | 1987 |
Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antiviral Agents; Humans; Immunotherapy; | 1988 |
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherap | 1987 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoace | 1987 |
Antiviral drugs for AIDS. Current status and future prospects.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I | 1986 |
Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Humans; Thymidine; U | 1988 |
AIDS commentary. Azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Clinical Trials as Topic; Humans; T | 1988 |
Assessment and management of the AIDS patient with neuropsychiatric disturbances.
Topics: Acquired Immunodeficiency Syndrome; Anxiety; Humans; Male; Neurocognitive Disorders; Social Support; | 1988 |
[Experimental chemotherapy of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptide | 1988 |
Treatment of human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; HIV; Humans; Ribavi | 1987 |
AIDS-related Kaposi's sarcoma: therapeutic modalities.
Topics: Acquired Immunodeficiency Syndrome; Bone Marrow Transplantation; Combined Modality Therapy; Doxorubi | 1987 |
Strategies for the future chemotherapy of human immunodeficiency virus (HIV).
Topics: Acquired Immunodeficiency Syndrome; Drug Evaluation; HIV; Humans; Thymidine; Zidovudine | 1987 |
AIDS dementia: a review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Brain; Counseling; Dementia; Humans; Nervous S | 1987 |
Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.
Topics: Acquired Immunodeficiency Syndrome; HIV; Humans; Structure-Activity Relationship; Thymidine; Zidovud | 1987 |
30 trials available for thymidine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Met | 2004 |
A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in HIV-1-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Anti-HIV Agents; Drug Therapy, Combination; Genome, | 2004 |
[Chemotherapy and immunoprophylaxis of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Foscarnet; HIV; Huma | 1986 |
Progress in antiviral drug and vaccine development assessed at international AIDS conference.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Clinical Trials as Topic; Deoxycytidi | 1987 |
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Clinical Trials as Topic; Dementia; Humans; Male; M | 1988 |
AIDS. Treatment strategies and the Minnesota AIDS Clinical Trials Unit.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; Human | 1988 |
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Body Weight; Clinical Trials as Topic; Del | 1986 |
Zidovudine (AZT)
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; Zidovudine | 1987 |
Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antigens, Viral; Antiviral Agents; Double-Blind Metho | 1988 |
AIDS drug shows promise in preliminary clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Deltaretrovirus; Hum | 1986 |
[Azidothymidine and HIV infection].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic | 1987 |
Prophylactically administered Retrovir in health care workers potentially exposed to the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Allied Health Personnel; Clinical Trials as Topic; Double-Blind | 1988 |
Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Humans; Thymidine; U | 1988 |
Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; | 1988 |
Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antigens, Viral; Antiviral Agents; Clinica | 1988 |
AIDS commentary. Azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Clinical Trials as Topic; Humans; T | 1988 |
The FDA's new procedures for the use of investigational drugs in treatment.
Topics: Acquired Immunodeficiency Syndrome; Catastrophic Illness; Clinical Protocols; Clinical Trials as Top | 1988 |
Commercial venture to speed up AIDS drug tests in California.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Drug Industry; Human | 1988 |
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Clinical Trials as Topic | 1987 |
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; AIDS-Related Complex; Anemia; Antiviral Ag | 1987 |
Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. A challenge to the medical and pharmaceutical communities.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Drug Utilization; Hu | 1987 |
"On the shelf" AIDS drug in clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Fusidic Acid; HIV; Humans; Thymidine; | 1987 |
Zidovudine approved by FDA for treatment of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Clinical Trials as Topic; Humans; Thymi | 1987 |
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Antiviral Agents; Drug Evaluation; Erythrocyte In | 1988 |
Senate votes to expand anti-AIDS drug trials.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Government Agencies; Humans; National | 1986 |
Promising results halt trial of anti-AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Humans; Thymidine; Zidovudine | 1986 |
Azidothymidine for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Bone Marrow Diseases; Clinical Tria | 1986 |
Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Biological Availability; Chromatography, H | 1987 |
Report from the war zone.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Humans; New York Cit | 1987 |
[Clinical trial with a new drug in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; | 1986 |
122 other studies available for thymidine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers.
Topics: Acquired Immunodeficiency Syndrome; CD4 Antigens; Cytidine; DNA Primers; Female; Genetic Predisposit | 2009 |
Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; | 2003 |
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Substitution; Anti-HIV Agents; CD4 Lymphocyte Count; | 2004 |
Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2.
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; Humans; Interleukin-1; Interleukin-2; Leukocyte | 1984 |
Interleukin regulation of the immune system (IRIS) in male homosexuals with acquired immune deficiency disease syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Homosexuality; Humans; In Vitro Techniques; Indomethacin; | 1984 |
Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Topics: Acquired Immunodeficiency Syndrome; Benzoquinones; Blotting, Western; Calcium-Calmodulin-Dependent P | 1993 |
Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Blotting, Northern; Cell Division; Cell Line; Endothelium, Vascu | 1995 |
AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.
Topics: Acquired Immunodeficiency Syndrome; Dexamethasone; Drug Synergism; Growth Substances; Humans; Mifepr | 1995 |
Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin.
Topics: Acquired Immunodeficiency Syndrome; Cell Division; Cell Survival; Doxorubicin; Drug Carriers; Humans | 1993 |
Perturbation of the immunosuppressive action of glucocorticoids in rat thymocytes by liposoluble extracts of serum from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cells, Cultured; Cytosol; Dexamethasone; Fatty Acids, N | 1993 |
TSAO analogues. 3. Synthesis and anti-HIV-1 activity of 2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl 3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) purine and purine-modified nucleosides.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cells, Cultured; HIV-1; Humans; Magnetic Reson | 1993 |
Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Topics: Acquired Immunodeficiency Syndrome; Antibody-Dependent Cell Cytotoxicity; B-Lymphocytes; Base Sequen | 1993 |
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Carbon Radioisotopes; Humans; Lymphoma, AIDS-Rel | 2002 |
In vitro immunomodulatory effects of traditional Kampo medicine (sho-saiko-to: SST) on peripheral mononuclear cells in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; DNA Replication; Drugs, Chinese Herbal; | 1990 |
Biochemical changes in ethanol-treated HL-60 cells.
Topics: Acquired Immunodeficiency Syndrome; Alcoholism; Biological Transport, Active; DNA; Ethanol; Humans; | 1990 |
Cortisol resistance in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Addison Disease; Adult; Circadian Rhythm; Dexamethasone; DNA Rep | 1992 |
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Deltaretrovirus; Gene Products, gag; Humans; R | 1985 |
Antiviral therapy. New drugs and their uses.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Common Cold | 1986 |
Antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus; DNA, Viral; Drug R | 1987 |
[We can perhaps hold AIDS in check but we cannot cure it].
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antiviral Agents; Humans; Reverse Transc | 1987 |
Antiviral chemotherapy.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Herpes Simplex; Herpes Zoster; Huma | 1988 |
Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Amino Acids; Cells, Cultured; Cysteine; Cystine; Female; Glutath | 1989 |
Therapy for neurological involvement in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Blood-Brain Barrier; Central Nervous System Diseases; Deoxycytid | 1988 |
Can AZT treatment in AIDS patients aggravate pre-existing CMV retinitis?
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Humans; Mal | 1988 |
Atypical retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Cytomegalovirus Infections; Fluorescein Angiog | 1988 |
Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Fundus Oculi; Humans; Male; R | 1988 |
Azidothymidine neurotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Adult; Epilepsies, Partial; Humans; Male; Opportunistic Infectio | 1986 |
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Humans; Male; Middle Aged; Nervous System | 1987 |
Wernicke's encephalopathy in AIDS patient treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Thymidine; Wernicke Encephalopathy; Z | 1987 |
Serum thymidine kinase in AIDS patients treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Humans; Thymidine; Thymidine Kinase; Zidovudine | 1987 |
Remission of AIDS-associated psoriasis with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Humans; Male; Psoriasis; Thymidine; | 1987 |
Zidovudine for lymphocytic interstitial pneumonia associated with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Humans; Male; Middle Aged; Pulmonary Fi | 1987 |
Zidovudine for lymphocytic interstitial pneumonitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Pulmonary Fibrosis; Thymidine; Zidovu | 1987 |
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Deoxycytidine; Drug Administration | 1988 |
Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Resistance; Etretinate; Homosexual | 1987 |
Resumption of HIV antigen production during continuous zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; HIV; Humans; Thymidine; Zidov | 1988 |
Post-exposure prophylaxis against HIV infection in health care workers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Female; Humans; Laboratory Infection; T | 1988 |
Isolation of HIV from mononuclear cells of patients receiving zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; HIV; Humans; Leuk | 1988 |
Necrotising myopathy and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Humans; Male; Muscular Diseases; Necrosis; Thymid | 1988 |
Update on AIDS--new video cassette.
Topics: Acquired Immunodeficiency Syndrome; Congresses as Topic; Drug Therapy; Humans; Immunotherapy; Thymid | 1988 |
Acute meningo-encephalitis on dose reduction of zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Complex; Antiviral Agents; Fo | 1988 |
Increased frequency of haemarthroses in haemophilic patient treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Hemarthrosis; Hemophilia A; Humans; Male; Middle Aged; Thymidine | 1988 |
IVth international AIDS conference.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies, Viral; Child; Congresses as Topic; Female; He | 1988 |
Acyclovir-resistant herpes in AIDS treated with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; | 1988 |
Zidovudine overdose.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Thymidine; Zidovudine | 1988 |
Acute meningoencephalitis on dose reduction of zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; HIV; Humans; Meningoencephalitis; Thymidine; Viru | 1988 |
Zidovudine-associated myopathy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Muscular Diseases; Thymidine; Zidovudi | 1988 |
AIDS: the virus, antivirals and vaccines.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans | 1987 |
Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Complex; Antiviral Agents; Drug I | 1988 |
[Dysautonomic orthostatic hypotension in human immunodeficiency virus infection. Remission in azidovudine therapy].
Topics: Acquired Immunodeficiency Syndrome; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Huma | 1988 |
The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antibodies, Viral; Antiviral Agents | 1988 |
Anti-AIDS agents show varying early results in vitro and in vivo.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; | 1985 |
In search of the best drugs against AIDS.
Topics: Acquired Immunodeficiency Syndrome; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Zidovudi | 1986 |
3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; Antineoplastic Agents; Antiviral Age | 1987 |
Management of viral infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Herpes | 1987 |
Brain damage by AIDS under active study.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Cell | 1987 |
TPA and PDQ.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Quality Control; Thymidine; Tissue Pla | 1987 |
Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine).
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antigens, Differentiation, T-Lympho | 1987 |
Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Surface; Antigens, Viral; Cell Line; HIV; Humans; Poly | 1987 |
The blood transfusion service and zidovudine treatment for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Antiviral Agents; Blood Transfusion; Humans; Thymidine; | 1987 |
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Central Nervous System Diseases; HIV; HIV Antig | 1988 |
Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Agranulocytosis; Humans; Leukocyte Count; Lithium; Lithiu | 1988 |
Treatment of human immunodeficiency virus-related polyneuropathy with 3'-azido-2',3'-dideoxythymidine.
Topics: Acquired Immunodeficiency Syndrome; Aged; Female; Humans; Leg; Nervous System Diseases; Neural Condu | 1988 |
AZT helpful in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; Zidovudine | 1988 |
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Chromatography, High Pressure Liquid; Huma | 1988 |
Health of Toronto's street kids disturbing, study reveals.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adolescent Behavior; Antiviral Agents; Attitude to H | 1988 |
Recovery from cryptococcemia and the adult respiratory distress syndrome in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antiviral Agents; Cryptococcosis; Humans; | 1988 |
Manic syndrome associated with zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Bipolar Disorder; Cognition Disorders; | 1988 |
[HIV infection and AIDS. Paris, 25-29 January 1988].
Topics: Acquired Immunodeficiency Syndrome; Antibody Formation; HIV; Humans; Thymidine; Zidovudine | 1988 |
Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Enterocolitis, Pseudomembranous; Humans; Male; Middle | 1988 |
Prophylactic Retrovir study for health care workers.
Topics: Acquired Immunodeficiency Syndrome; Health Occupations; Humans; Thymidine; Zidovudine | 1988 |
Update on AIDS--new video cassette.
Topics: Acquired Immunodeficiency Syndrome; Forecasting; Humans; Research; Thymidine; Videotape Recording; Z | 1988 |
AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system.
Topics: Acquired Immunodeficiency Syndrome; Animals; Brain; Cell Line; Chemical Phenomena; Chemistry; Dement | 1988 |
Response of human immunodeficiency virus-associated uveitis to zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Humans; Male; Thymidine; Uveitis; V | 1988 |
From the Food and Drug Administration. Update on zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; United States; United State | 1988 |
Resolution of oral hairy leukoplakia during treatment with azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Homosexuality; Humans; Leukoplakia, Ora | 1988 |
Study to examine use of retrovir.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Evaluation; Humans; Occupational Diseases | 1988 |
Pharmacokinetics and bioavailability of zidovudine in humans.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Biological Availa | 1988 |
Zidovudine therapy in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Child; Child, Preschool; Drug Administration S | 1988 |
Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Bronchial Diseases; Bronchoscopy; Femal | 1988 |
[Severe anemia after administration of zidovudine].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Humans; Male; Thymidine; Zidovudine | 1988 |
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Brain; Brain Diseases; Child; Child, Preschool; Follow-Up Studie | 1988 |
AIDS update--a roundup of news and trends.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; Zidovudine | 1988 |
Thrombocytopenia, the acquired immunodeficiency syndrome (AIDS), and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Thrombocytopenia; Thymidine; Zidovudine | 1988 |
Resolution of resistant chronic herpetic lesions with zidovudine in a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Chronic Disease; Herpes Simplex; Humans; Male; Opportunis | 1988 |
Treatment of pneumocystis pneumonia in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Humans; Pneumonia, Pneumocystis; Thymid | 1988 |
Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Antiviral Agents; Granuloma; Humans; Male; Pent | 1988 |
Zidovudine-induced nail pigmentation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Nail Diseases; Opportunistic Infections; Pi | 1988 |
State Medicaid coverage of AZT and AIDS-related policies.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Hospices; Humans; Insurance Benefits; Insuranc | 1988 |
Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Agranulocytosis; Antiviral Agents; Humans; Kidney Transpl | 1988 |
Azidothymidine in the treatment of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Humans; Male; Thymidine; Zidovudine | 1988 |
AIDS-associated psoriasis responds to azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Psoriasis; Thymidine; Zidovudine | 1988 |
The effect of azidothymidine on HIV-related thrombocytopenia.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Platelet Count; Thrombocytopenia; Thym | 1988 |
AIDS drug patent.
Topics: Acquired Immunodeficiency Syndrome; Humans; Patents as Topic; Thymidine; United States; Zidovudine | 1988 |
Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Humans; Myositis; Thymidine; Zidovudine | 1988 |
AIDS drug assistance program.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Medical Assistance; New York; Thymidin | 1988 |
Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; HIV; HIV Antigens; Humans; Th | 1986 |
Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Interactions; Herpes Si | 1987 |
AZT (zidovudine) just a step away from FDA approval for AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; United States; United State | 1987 |
Imminent marketing of AZT raises problems.
Topics: Acquired Immunodeficiency Syndrome; Humans; Thymidine; Zidovudine | 1987 |
FDA approves AZT.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Humans; Thymidine; United States; United S | 1987 |
Azidothymidine and human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; Zidovudine | 1987 |
Availability of AZT for treatment of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Humans; Thymidine; United States; Zidovudine | 1987 |
"Cure" of chronic cryptosporidiosis during treatment with azidothymidine in a patient with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Chronic Disease; Cryptosporidiosis; Diarrhea; Humans; Mal | 1987 |
AIDS research: the ethics of clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Beneficence; Clinical Trials as Topic; Control | 1986 |
Antiretroviral therapy for AIDS.
Topics: Acquired Immunodeficiency Syndrome; DNA, Viral; Humans; Thymidine; Zidovudine | 1987 |
Profound cytopenia secondary to azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Pancytopenia; Thymidine; Zidovudine | 1987 |
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Bone Marrow Diseases; Humans; Male; Mid | 1987 |
Promoting Retrovir.
Topics: Acquired Immunodeficiency Syndrome; Advertising; Drug Industry; Humans; Thymidine; United States; Zi | 1987 |
Zidovudine and the anaesthetist.
Topics: Acquired Immunodeficiency Syndrome; Anesthesiology; Anesthetics; Antiviral Agents; Drug Interactions | 1987 |
Azidothymidine (AZT).
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; HIV; Humans; Thymidine; Zidovudine | 1987 |
AZT in hemophilia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Blood Platelets; Hemophilia A; Humans; Male; Thymidine; Z | 1987 |
Update on AZT for AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Drug Interactions; Hemat | 1987 |
Nail pigmentation in the acquired immunodeficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Humans; Male; Nail Diseases; Pigmentati | 1987 |
A pinch of will is better than a pound of perhaps.
Topics: Acquired Immunodeficiency Syndrome; Adult; Attitude to Health; Humans; Male; Social Support; Thymidi | 1987 |
A little more to improve safety and efficiency of AZT in AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Thymidine; Zidovudine | 1987 |
[AIDS and antiretroviral agents: specificity of azidothymidine].
Topics: Acquired Immunodeficiency Syndrome; Humans; Thymidine; Zidovudine | 1987 |
Zidovudine for AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Humans; Thymidine; Zidov | 1987 |
Nail pigmentation changes associated with azidothymidine (zidovudine).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Black People; Female; Humans; Male; Nai | 1987 |
Prophylaxis against Pneumocystis carinii pneumonia in patients receiving azidothymidine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Humans; Male; Middle Aged; Pneumonia, Pneumocysti | 1987 |
Antiviral agents.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpes Sim | 1987 |
The AIDS virus.
Topics: Acquired Immunodeficiency Syndrome; Animals; Chlorocebus aethiops; Genes, Viral; History, 20th Centu | 1987 |